• Order to parcel locker

    Order to parcel locker
  • easy pay

    easy pay
  • Reduced price
Medication-Induced Movement Disorders

Medication-Induced Movement Disorders

9781316636817
264.54 zł
238.08 zł Save 26.46 zł Tax included
Lowest price within 30 days before promotion: 238.08 zł
Quantity
Available in 4-6 weeks

  Delivery policy

Choose Paczkomat Inpost, Orlen Paczka, DPD or Poczta Polska. Click for more details

  Security policy

Pay with a quick bank transfer, payment card or cash on delivery. Click for more details

  Return policy

If you are a consumer, you can return the goods within 14 days. Click for more details

Description
Medications that may produce movement disorders are widely used. The resulting disorders are often highly disconcerting for the patient and their relatives, especially when the connection between medication and disorder is not recognized. However, ascribing an adverse drug effect to medication exposure is often difficult, especially when the side effect is rare. Covering various drugs - including the major classes of medications working primarily on the brain, specifically antipsychotics and antidepressants - this all-encompassing review of medication-induced movement disorders aids early recognition and improved treatment. The problem of what to do when the offending medication cannot be reduced is also reviewed. It discusses the best options for evaluation and treatment, including medical imaging and deep brain stimulation, and guides the clinician in managing the disorder, making this a vital reference for medical specialists and consultants in neurology and neuropharmacology and any clinician seeing patients on medications crossing the blood-brain barrier.
Product Details
82670
9781316636817
9781316636817

Data sheet

Publication date
2020
Issue number
1
Cover
paperback
Dimensions (mm)
190.00 x 256.00
Weight (g)
510
  • List of contributors; Dedication; Introduction; 1. Acute akathisia Drew S. Kern and Anthony E. Lang; 2. Acute dystonia Anne Marthe Meppelink and Mark J. Edwards; 3. Neuroleptic malignant syndrome Atbin Djamashidian and Sean S. OSullivan; 4. Serotonin syndrome Dimitrios A. Nacopoulos and Hubert H. Fernandez; 5. Neuroleptic Parkinsonism Joseph H. Friedman; 6. Tardive syndromes Daniel Tarsy and Raminder Parihar; 7. Tardive dyskinesia treatment Tracy M. Jones, Israt Jahan and Theresa A. Zesiewicz; 8. Atypical antipsychotics and movement disorders Rob M. A. de Bie; 9. Restless legs syndrome Roongroj Bhidayasiri and Pattamon Panyakaew; 10. Medication-induced tremors Peter A. Lewitt; 11. L-Dopa dyskinesias Juan Ramirez-Castaneda and Joseph Jankovic; 12. VPA, lithium, amiodarone and other non-DA Michael Silver and Stewart A. Factor; 13. Anti-depressants and movement disorders Gilles Fenelon; 14. Ataxia Marina Sanchez Abraham and Oscar S. Gershanik; 15. Myoclonus and asterixis P. D. Thompson, T. J. Kleinig and T. E. Kimber; 16. Imaging in medication-induced Parkinsonism Danna Jennings; 17. Deep brain stimulation for Tardive disorders Bernardo Rodrigues and Kelvin L. Chou; Index.
Comments (0)